IMARC Group, a leading market research company, has recently releases report titled “Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global fertility services market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the fertility services market?
- Market Size in 2022: US$ 35.2 Billion
- Market Forecast in 2028: US$ 84.0 Billion
- Growth rate (2023 to 2028): CAGR of 15.5%
- Base Year of the Analysis: 2022
- Forecast Period: 2023-2028
What are fertility services?
Infertility is a medical condition that is defined by the inability to achieve pregnancy, which is caused by numerous factors, including abnormal sperm functions or production, ovulation disorders, abnormal hormone level, issues related to sperm delivery, chronic diseases, and fallopian tube damage or blockage. Fertility services are medical treatments and procedures designed to help individuals or couples who are having difficulty conceiving a child. These services include a wide range of options, from simple lifestyle changes and medications to more complex procedures such as in vitro fertilization (IVF) and intrauterine insemination (IUI). These services are offered by reproductive endocrinologists, specialists who are trained in diagnosing and treating infertility.
Request to get the sample report: https://www.imarcgroup.com/fertility-services-market/requestsample
What are the growth prospects and trends in the fertility services industry?
The market is primarily driven by the growing prevalence of infertility among the masses. This can be supported by the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS), and sexually transmitted diseases (STDs). Moreover, the growing awareness among individuals and increasing accessibility to improved healthcare facilities are creating a positive market outlook. Besides, several leading players are focussing on extensive research and development (R&D) activities in the field of life science and biotechnology, which is impacting the market favorably. Other factors, including the Increasing prevalence of same-sex relationships, inflating disposable income levels of individuals, and aggressive marketing strategies adopted by numerous leading players, are also influencing the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Cause of Infertility:
- Male Infertility
- Female Infertility
Breakup by Procedure:
- In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
- Surrogacy
- In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
- Intrauterine Insemination (IUI)
- Others
Breakup by Service:
- Fresh Non-Donor
- Frozen Non-Donor
- Egg and Embryo Banking
- Fresh Donor
- Frozen Donor
Breakup by End-User:
- Fertility Clinics
- Hospitals
- Surgical Centres
- Clinical Research Institutes
- Cryobanks
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
- Instituto Bernabe
- INVO Bioscience
- Monash IVF Group
- Apollo Hospitals Enterprise
- Care Fertility Group
- Carolinas Fertility Institute
- Genea Limited
- The Cooper Companies
- Virtus Health
- Vitrolife
- The Johns Hopkins Health System
- Medicover Group
- Ovascience
- Progyny
- Xytex Cryo International
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/